Osteoporosis Drugs Tied to Esophageal Cancer


September 3, 2010

ABC News

A second look at British registry data indicates that esophageal cancer may be more common after all in patients taking oral bisphosphonate drugs, a type of drug used to treat osteoporosis, for long periods.

In an analysis involving some 80,000 patients tracked for more than seven years on average, individuals diagnosed with esophageal cancer of were 1.93 times as likely to have received at least 10 prescriptions for oral bisphosphonates compared with controls not having cancer, reported Dr. Jane Green of the University of Oxford in England and colleagues online in BMJ... Read More